Citrate anticoagulation for extracorporeal circuits: Effects on whole blood coagulation activation and clot formation [2]

Nephron

Volumn 89, Issue 2, 2001, Pages 233-236

  Calatzis, A ^a   Toepfer, M ^a   Schramm, W ^a   Spannagl, M ^a   Schiffl, H ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CITRIC ACID; HEPARIN;

ANTICOAGULATION; BLEEDING; BLOOD CLOTTING; BLOOD CLOTTING TIME; CHELATION; DOSE RESPONSE; EXTRACORPOREAL CIRCULATION; FIBRIN FORMATION; HEMODIALYSIS; HEPARINIZATION; HUMAN; LETTER; PRIORITY JOURNAL; THROMBOELASTOGRAPHY;

ANTICOAGULANTS; BLOOD COAGULATION; CITRATES; EXTRACORPOREAL CIRCULATION; HUMANS;

EID: 0034824516     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000046075     Document Type: Letter

References (11)

1. Hemorrhage during high-risk hemodialysis using controlled heparinization
2. Bleeding in renal failure
3. Extracorporeal management of acute renal failure patients at high risk of bleeding
4. Regional citrate anticoagulation for hemodialysis in a patient at high risk for bleeding
5. Regional hemodialysis anticoagulation: Hypertonic tri-sodium citrate or anticoagulant citrate dextrose-A
6. Citrate compared to low-molecular-weight heparin anticoagulation in chronic hemodialysis patients
7. The role of sodium citrate in the dysfibrinogenaemia of liver disease
8. Differential effects of divalent cations on fibrin structure
9. Dynamics of clot growth induced by thrombin diffusing into nonstirred citrate human plasma
10. Thrombelastography
11. Prothrombin activation induced by Ecarin - A prothrombin converting enzyme from Echis carinatus venom